-
1دورية أكاديمية
المؤلفون: Gilbert DC; MRC Clinical Trials Unit, University College London, London, UK. duncan.gilbert@ucl.ac.uk., Speirs V; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK. valerie.speirs@abdn.ac.uk.
المصدر: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2021 Apr; Vol. 18 (4), pp. 191-192.
نوع المنشور: Historical Article; Journal Article
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Biological Specimen Banks*/statistics & numerical data , Biological Specimen Banks*/trends , Clinical Trials as Topic*/methods , Clinical Trials as Topic*/statistics & numerical data , Radiation Genomics*/methods , Radiation Genomics*/organization & administration , Radiation Genomics*/trends , Radiotherapy*/adverse effects , Radiotherapy*/methods , Radiotherapy*/statistics & numerical data, Biomedical Research/methods ; Biomedical Research/organization & administration ; Biomedical Research/trends ; History, 20th Century ; History, 21st Century ; Humans ; Prognosis ; Radiation Injuries/diagnosis ; Radiation Injuries/epidemiology ; Radiation Injuries/genetics ; Radiation Injuries/pathology ; Radiation Oncology/methods ; Radiation Oncology/statistics & numerical data ; Radiation Oncology/trends ; Signal Transduction/genetics ; Signal Transduction/radiation effects ; Specimen Handling/standards ; Specimen Handling/statistics & numerical data ; Specimen Handling/trends ; Translational Research, Biomedical/methods ; Translational Research, Biomedical/organization & administration ; Translational Research, Biomedical/trends ; United Kingdom/epidemiology
-
2دورية أكاديمية
المؤلفون: Udayakumar D; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas.; Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, Texas.; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas., Zhang Z; Quantitative Biomedical Research Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas., Xi Y; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas.; Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas., Dwivedi DK; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Fulkerson M; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Haldeman S; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., McKenzie T; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas., Yousuf Q; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Joyce A; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Hajibeigi A; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Notgrass H; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas., de Leon AD; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Yuan Q; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Lewis MA; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Madhuranthakam AJ; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas.; Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, Texas., Sibley RC; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Elias R; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Guo J; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas., Christie A; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., McKay RM; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Cadeddu JA; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas.; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Urology, UT Southwestern Medical Center, Dallas, Texas., Bagrodia A; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Urology, UT Southwestern Medical Center, Dallas, Texas., Margulis V; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Brugarolas J; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Wang T; Quantitative Biomedical Research Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas.; Center for the Genetics of Host Defense, UT Southwestern Medical Center, Dallas, Texas., Kapur P; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.; Department of Urology, UT Southwestern Medical Center, Dallas, Texas., Pedrosa I; Department of Radiology, UT Southwestern Medical Center, Dallas, Texas. Ivan.Pedrosa@UTSouthwestern.edu.; Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, Texas.; Kidney Cancer Program - Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 01; Vol. 27 (17), pp. 4794-4806. Date of Electronic Publication: 2021 Jul 01.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Radiation Genomics* , Tumor Microenvironment*, Carcinoma, Renal Cell/*diagnostic imaging , Carcinoma, Renal Cell/*genetics , Carcinoma, Renal Cell/*pathology , Kidney Neoplasms/*diagnostic imaging , Kidney Neoplasms/*genetics , Kidney Neoplasms/*pathology , Magnetic Resonance Imaging/*methods, Adult ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/therapeutic use ; Carcinoma, Renal Cell/drug therapy ; Female ; Humans ; Kidney Neoplasms/drug therapy ; Male ; Middle Aged ; Prospective Studies
-
3دورية أكاديمية
المؤلفون: Moussa AM; Department of Interventional Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Suite H-112, New York, NY, 10065, USA., Ziv E; Department of Interventional Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Suite H-112, New York, NY, 10065, USA. zive@mskcc.org.
المصدر: Current oncology reports [Curr Oncol Rep] 2021 Jan 02; Vol. 23 (1), pp. 9. Date of Electronic Publication: 2021 Jan 02.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasms*/genetics , Neoplasms*/radiotherapy , Radiation Genomics* , Radiation Oncology*, Artificial Intelligence ; Humans
-
4دورية أكاديمية
المؤلفون: Yi X; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Central South University, Changsha 410008, PR China., Liu Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders, Changsha 410008, PR China., Zhou B; Xiangya School of Medicine, Central South University, Changsha 410013, PR China., Xiang W; Department of Radiology, Hunan Provincial Tumor Hospital, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410008, PR China., Deng A; Department of Radiology, Hunan Provincial Tumor Hospital, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410008, PR China., Fu Y; Department of Radiology, Hunan Provincial Tumor Hospital, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410008, PR China., Zhao Y; Department of Radiology, Hunan Provincial Tumor Hospital, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410008, PR China., Ouyang Q; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders, Changsha 410008, PR China., Liu Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders, Changsha 410008, PR China., Sun Z; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders, Changsha 410008, PR China., Zhang K; Hunan Provincial Tumor Hospital, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410008, PR China., Li X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders, Changsha 410008, PR China., Zeng F; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Central South University, Changsha 410008, PR China. Electronic address: zengfeiyue@csu.edu.cn., Zhou H; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410008, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410008, PR China; National Clinical Research Center for Geriatric Disorders, Changsha 410008, PR China., Chen BT; Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA, United States.
المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Jan; Vol. 133, pp. 111013. Date of Electronic Publication: 2020 Nov 20.
نوع المنشور: Journal Article; Validation Study
بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
مواضيع طبية MeSH: Multidetector Computed Tomography* , Pharmacogenomic Testing* , Pharmacogenomic Variants* , Polymorphism, Single Nucleotide* , Radiation Genomics*, Antineoplastic Agents/*therapeutic use , Drug Resistance, Neoplasm/*genetics , Ovarian Neoplasms/*drug therapy , Platinum Compounds/*therapeutic use , Sulfotransferases/*genetics, Chemotherapy, Adjuvant ; Cytoreduction Surgical Procedures ; Female ; Humans ; Machine Learning ; Middle Aged ; Observer Variation ; Ovarian Neoplasms/diagnostic imaging ; Ovarian Neoplasms/genetics ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies
-
5دورية أكاديمية
المؤلفون: Aguado-Barrera ME; Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Av. Choupana s/n, Edif. D, Planta 1, 15706, Santiago de Compostela, A Coruña, Spain; Fundación Pública Galega de Medicina Xenómica (FPGMX), Av. Choupana s/n, Edif. Consultas, Planta menos 2, 15706, Santiago de Compostela, A Coruña, Spain., Sosa-Fajardo P; Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Av. Choupana s/n, Edif. D, Planta 1, 15706, Santiago de Compostela, A Coruña, Spain; Department of Radiation Oncology, University Hospital Virgen del Rocío, Av. Manuel Siurot, s/n, 41013, Seville, Spain., Gómez-Caamaño A; Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Av. Choupana s/n, Edif. D, Planta 1, 15706, Santiago de Compostela, A Coruña, Spain; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago de Compostela, Servizo Galego de Saúde (SERGAS), Av. Choupana s/n, Edif. Consultas, Planta menos 3, 15706, Santiago de Compostela, A Coruña, Spain., Taboada-Valladares B; Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Av. Choupana s/n, Edif. D, Planta 1, 15706, Santiago de Compostela, A Coruña, Spain; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago de Compostela, Servizo Galego de Saúde (SERGAS), Av. Choupana s/n, Edif. Consultas, Planta menos 3, 15706, Santiago de Compostela, A Coruña, Spain., Couñago F; Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid, C. del Maestro Ángel Llorca 8, 28003, Madrid, Spain., López-Guerra JL; Department of Radiation Oncology, University Hospital Virgen del Rocío, Av. Manuel Siurot, s/n, 41013, Seville, Spain; Instituto de Biomedicina de Sevilla (IBIS/HUVR/CSIC/Universidad de Sevilla), C. Antonio Maura Montaner s/n, 41013, Seville, Spain., Vega A; Grupo Genética en Cáncer y Enfermedades Raras, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Av. Choupana s/n, Edif. D, Planta 1, 15706, Santiago de Compostela, A Coruña, Spain; Fundación Pública Galega de Medicina Xenómica (FPGMX), Av. Choupana s/n, Edif. Consultas, Planta menos 2, 15706, Santiago de Compostela, A Coruña, Spain; Biomedical Network on Rare Diseases (CIBERER), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, 28029, Madrid, Spain. Electronic address: ana.vega@usc.es.
المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Feb; Vol. 176, pp. 56-74. Date of Electronic Publication: 2023 Jan 02.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
-
6دورية أكاديمية
عنوان ترانسليتريتد: Médecine de précision et immunoradiothérapie.
المؤلفون: Chargari C; Service de curiethérapie, département d'oncologie radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France; Institut de recherche biomédicale des armées, Brétigny-sur-Orge, France; Radiothérapie moléculaire et thérapies innovantes, Inserm UMR1030, Gustave Roussy Cancer Campus, université Paris Saclay, Villejuif, France. Electronic address: cyrus.chargari@gustaveroussy.fr., Robert C; Service de curiethérapie, département d'oncologie radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France; Radiothérapie moléculaire et thérapies innovantes, Inserm UMR1030, Gustave Roussy Cancer Campus, université Paris Saclay, Villejuif, France., Genestie C; Département d'anatomopathologie, Gustave Roussy Cancer Campus, Villejuif, France., Deutsch E; Service de curiethérapie, département d'oncologie radiothérapie, Gustave Roussy Cancer Campus, Villejuif, France; Radiothérapie moléculaire et thérapies innovantes, Inserm UMR1030, Gustave Roussy Cancer Campus, université Paris Saclay, Villejuif, France.
المصدر: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2021 Oct; Vol. 25 (6-7), pp. 570-575. Date of Electronic Publication: 2021 Aug 11.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Country of Publication: France NLM ID: 9711272 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6658 (Electronic) Linking ISSN: 12783218 NLM ISO Abbreviation: Cancer Radiother Subsets: MEDLINE
مواضيع طبية MeSH: Immunotherapy/*methods , Neoplasms/*therapy , Precision Medicine/*methods , Radiotherapy/*methods, B7-H1 Antigen/metabolism ; Combined Modality Therapy/methods ; DNA Mismatch Repair ; Eosinophils ; Genome, Human ; Humans ; Interferon Type I/metabolism ; Interferon Type I/radiation effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Mutation ; Neoplasms/genetics ; Neoplasms/immunology ; Programmed Cell Death 1 Receptor/metabolism ; Radiation Genomics
-
7دورية أكاديمية
المؤلفون: Scott JG; Translational Hematology and Oncology Research, Radiation Oncology Department, Cleveland Clinic, Cleveland, OH, USA; Systems Biology and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA., Sedor G; School of Medicine, Case Western Reserve University, Cleveland, OH, USA., Ellsworth P; School of Medicine, Case Western Reserve University, Cleveland, OH, USA., Scarborough JA; Translational Hematology and Oncology Research, Radiation Oncology Department, Cleveland Clinic, Cleveland, OH, USA; Systems Biology and Bioinformatics, Case Western Reserve University, Cleveland, OH, USA., Ahmed KA; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA., Oliver DE; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA., Eschrich SA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA., Kattan MW; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Torres-Roca JF; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL, USA. Electronic address: Javier.torresroca@moffitt.org.
المصدر: The Lancet. Oncology [Lancet Oncol] 2021 Sep; Vol. 22 (9), pp. 1221-1229. Date of Electronic Publication: 2021 Aug 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Radiotherapy Dosage*, Neoplasms/*radiotherapy , Radiation Genomics/*methods, Databases, Factual ; Humans ; Neoplasms/genetics ; Neoplasms/mortality ; Precision Medicine ; Recurrence ; Survival Rate
-
8دورية أكاديمية
المؤلفون: Jandee Lee, Seonhyang Jeong, Hwa Young Lee, Sunmi Park, Meesson Jeong, Young Suk Jo
المصدر: Endocrinology and Metabolism, Vol 38, Iss 6, Pp 720-728 (2023)
مصطلحات موضوعية: thyroid cancer, papillary, radiation genomics, transcriptome, geographic locations, nuclear power plants, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
وصف الملف: electronic resource
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: Javier F. Torres-Roca, Michael W. Kattan, Geoffrey Sedor, Steven A. Eschrich, Jacob G. Scott, Jessica A. Scarborough, Patrick Ellsworth, Kamran Ahmed, Daniel E. Oliver
المصدر: The Lancet Oncology. 22:1221-1229
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Databases, Factual, business.industry, Proportional hazards model, Endometrial cancer, medicine.medical_treatment, Head and neck cancer, Hazard ratio, Cancer, Radiotherapy Dosage, medicine.disease, Survival Rate, Radiation therapy, Breast cancer, Recurrence, Neoplasms, Internal medicine, Radiation Genomics, medicine, Humans, Precision Medicine, business, Lung cancer